{"id":46457,"date":"2022-07-21T22:02:01","date_gmt":"2022-07-21T20:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/"},"modified":"2022-07-21T22:02:01","modified_gmt":"2022-07-21T20:02:01","slug":"ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/","title":{"rendered":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call"},"content":{"rendered":"
\n

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc.<\/a> (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event passcode 4671230. To access the webcast, please visit the Investors section of Ironwood\u2019s website at www.ironwoodpharma.com<\/a> at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.\n<\/p>\n

<\/a><\/p>\n

\nThe call will be available for replay via telephone starting Thursday, August 4, 2022 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on August 18, 2022. To listen to the replay, dial (800) 770-2030 (U.S. and Canada) or (647) 362-9199 (international) using conference ID number 4671230. The archived webcast will be available on Ironwood\u2019s website for 14 days beginning approximately one hour after the call has completed.\n<\/p>\n

\nAbout Ironwood Pharmaceuticals
\n
<\/b>Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600\u00ae company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS\u00ae (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Under the guidance of our seasoned industry leaders, we continue to build upon our history of GI innovation and challenge what has been done before to shape what the future holds. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.\n<\/p>\n

\nFounded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.\n<\/p>\n

\nWe routinely post information that may be important to investors on our website at www.ironwoodpharma.com<\/a>. In addition, follow us on Twitter<\/a> and on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors:<\/b>
Greg Martini, 617-374-5230
\n
gmartini@ironwoodpharma.com<\/a>\n<\/p>\n

\nMatt Roache, 617-621-8395
\n
mroache@ironwoodpharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46457","6":"format-standard","7":"category-industry"},"yoast_head":"\nIronwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T20:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call\",\"datePublished\":\"2022-07-21T20:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/\"},\"wordCount\":344,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005022\\\/en\\\/618520\\\/21\\\/IRWD_Logo_Color_Vertical_RD_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/\",\"name\":\"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005022\\\/en\\\/618520\\\/21\\\/IRWD_Logo_Color_Vertical_RD_RGB.jpg\",\"datePublished\":\"2022-07-21T20:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005022\\\/en\\\/618520\\\/21\\\/IRWD_Logo_Color_Vertical_RD_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005022\\\/en\\\/618520\\\/21\\\/IRWD_Logo_Color_Vertical_RD_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/","og_locale":"en_US","og_type":"article","og_title":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend","og_description":"BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-21T20:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call","datePublished":"2022-07-21T20:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/"},"wordCount":344,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/","url":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/","name":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg","datePublished":"2022-07-21T20:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220721005022\/en\/618520\/21\/IRWD_Logo_Color_Vertical_RD_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ironwood-pharmaceuticals-to-host-second-quarter-2022-investor-update-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46457"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46457\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}